Needham & Company LLC Issues Positive Forecast for MKS (NASDAQ:MKSI) Stock Price

MKS (NASDAQ:MKSI) had its price objective raised by equities research analysts at Needham & Company LLC from $170.00 to $210.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the scientific and technical instruments company’s stock. Needham & Company LLC’s price target points to a potential upside of 9.16% from the company’s previous close.

Other research analysts have also issued reports about the company. Benchmark raised their price objective on MKS from $135.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, November 7th. Morgan Stanley restated an “overweight” rating and issued a $151.00 price target on shares of MKS in a report on Monday, October 13th. Wells Fargo & Company lifted their price objective on shares of MKS from $135.00 to $150.00 and gave the company an “equal weight” rating in a research note on Friday, November 7th. Wall Street Zen downgraded shares of MKS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 3rd. Finally, Bank of America lifted their price target on shares of MKS from $200.00 to $215.00 and gave the stock a “buy” rating in a research note on Tuesday. Nine investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $180.55.

MKS Trading Up 3.5%

Shares of MKS stock traded up $6.46 during trading hours on Tuesday, reaching $192.38. The stock had a trading volume of 502,727 shares, compared to its average volume of 732,262. The firm has a market capitalization of $12.92 billion, a price-to-earnings ratio of 46.50, a P/E/G ratio of 1.71 and a beta of 1.92. MKS has a 1 year low of $54.84 and a 1 year high of $192.13. The company has a current ratio of 2.86, a quick ratio of 1.81 and a debt-to-equity ratio of 1.64. The firm has a 50 day simple moving average of $158.77 and a two-hundred day simple moving average of $130.02.

MKS (NASDAQ:MKSI) last posted its quarterly earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.80 by $0.13. MKS had a net margin of 7.25% and a return on equity of 20.80%. The firm had revenue of $988.00 million for the quarter, compared to analyst estimates of $963.87 million. During the same quarter last year, the firm posted $1.72 earnings per share. MKS’s revenue for the quarter was up 10.3% compared to the same quarter last year. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. As a group, equities research analysts anticipate that MKS will post 6.94 earnings per share for the current year.

Insider Activity at MKS

In other MKS news, Director Elizabeth Mora sold 300 shares of the company’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total value of $47,643.00. Following the transaction, the director owned 18,963 shares of the company’s stock, valued at approximately $3,011,514.03. This represents a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.51% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On MKS

A number of institutional investors and hedge funds have recently modified their holdings of MKSI. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of MKS by 3.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after purchasing an additional 9,170 shares in the last quarter. Parallel Advisors LLC increased its holdings in MKS by 63.9% in the second quarter. Parallel Advisors LLC now owns 952 shares of the scientific and technical instruments company’s stock worth $95,000 after buying an additional 371 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its position in MKS by 265.5% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 837 shares of the scientific and technical instruments company’s stock valued at $83,000 after acquiring an additional 608 shares in the last quarter. Wedmont Private Capital bought a new position in MKS during the second quarter valued at approximately $280,000. Finally, Assenagon Asset Management S.A. acquired a new stake in MKS in the second quarter valued at approximately $991,000. 99.79% of the stock is owned by institutional investors and hedge funds.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.